CONTRAVE
Identification of Contrave
| No description |
Google image searchProduct monograph
Active ingredients
naltrexone hydrochloride, 8 MG
bupropion hydrochloride, 90 MG
DIN: 02472945
Dosage form(s): TABLET (EXTENDED-RELEASE)
Route(s) of administration: ORAL
Schedule: Prescription
Company: BAUSCH HEALTH, CANADA INC.
Date: 02-JUN-2020
ATC:
- A08 — ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS (ATC, ATC/DDD, )
- A08A — ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS (ATC, ATC/DDD)
- A08AA — Centrally acting antiobesity products (ATC, ATC/DDD)
- A08AA62 — BUPROPION AND NALTREXONE (ATC/DDD)
Reference brand drug: Contrave
